Glucokinase Inactivation Paradoxically Ameliorates Glucose Intolerance by Increasing β-Cell Mass in
Journal
Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
27
08
2020
accepted:
22
01
2021
pubmed:
21
2
2021
medline:
24
8
2021
entrez:
20
2
2021
Statut:
ppublish
Résumé
Efficacy of glucokinase activation on glycemic control is limited to a short-term period. One reason might be related to excess glucose signaling by glucokinase activation toward β-cells. In this study, we investigated the effect of glucokinase haploinsufficiency on glucose tolerance as well as β-cell function and mass using a mouse model of type 2 diabetes. Our results showed that in
Identifiants
pubmed: 33608422
pii: db20-0881
doi: 10.2337/db20-0881
doi:
Substances chimiques
Glucokinase
EC 2.7.1.2
Glucose
IY9XDZ35W2
Banques de données
figshare
['10.2337/figshare.13626674']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
917-931Informations de copyright
© 2021 by the American Diabetes Association.